Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CORT vs $VTRS | Chartloom

Compare

$CORT vs $VTRS

Corcept Therapeutics Inc · Viatris Inc

CORT

Corcept Therapeutics Inc

VTRS

Viatris Inc

Compare $CORT vs $VTRS

Comparing Corcept Therapeutics Inc and Viatris Inc

CORTCorcept Therapeutics Inc

VTRSViatris Inc

CORTCorcept Therapeutics Inc

Market cap

$12.73B

P/E (TTM)

252.72x

Forward P/E (NTM)

28.94x

Forward P/S (NTM)

8.27x

Rev growth (TTM)

16.0%

YTD performance

208.4%

52W performance

59.3%

FCF yield

0.8%

VTRSViatris Inc

Market cap

$20.09B

P/E (TTM)

—

Forward P/E (NTM)

6.60x

Forward P/S (NTM)

1.33x

Rev growth (TTM)

4.4%

YTD performance

38.4%

52W performance

77.1%

FCF yield

9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CORT

VTRS

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

VTRS

Viatris Inc

Market Cap

CORT$12.73B

VTRS$20.09B

Enterprise Value

CORT$12.62B

VTRS$32.55B

Price

CORT$117.80

VTRS$17.25

P/E Ratio

CORT252.72x

VTRSN/A

P/S Ratio

CORT15.33x

VTRS1.36x

EV/Sales

CORT15.19x

VTRS2.21x

EV/EBITDA

CORT1,442.80x

VTRS8.00x

P/B Ratio

CORT18.56x

VTRS1.42x

P/FCF Ratio

CORT119.10x

VTRS11.09x

EV/FCF

CORT118.06x

VTRS17.96x

PEG Ratio

CORTN/A

VTRSN/A

Forward P/E (NTM)

CORT28.94x

VTRS6.60x

Forward P/S (NTM)

CORT8.27x

VTRS1.33x

Revenue (TTM)

CORT$831M

VTRS$14.74B

Revenue Growth (YoY)

CORT16.0%

VTRS4.4%

Forward Rev Growth

CORT48.8%

VTRS2.0%

Gross Margin (TTM)

CORT98.3%

VTRS40.3%

Operating Margin (TTM)

CORT0.8%

VTRS0.0%

EBITDA Margin (TTM)

CORT1.0%

VTRS27.2%

Net Margin (TTM)

CORT6.6%

VTRS-2.8%

FCF Margin (TTM)

CORT12.9%

VTRS12.3%

Net Income (TTM)

CORT$55M

VTRS$-411M

FCF (TTM)

CORT$107M

VTRS$1.81B

EPS (TTM)

CORT$0.47

VTRS-$0.35

ROE (TTM)

CORT8.4%

VTRS-279.0%

ROA (TTM)

CORT6.6%

VTRS-112.0%

ROIC (TTM)

CORT8.4%

VTRS-142.0%

Cash

CORT$111M

VTRS$887M

Debt

CORT$0

VTRS$13.35B

Net Cash/Debt

CORT$111M

VTRS$-12.46B

Current Ratio (TTM)

CORT2.86x

VTRS1.58x

Quick Ratio (TTM)

CORT2.63x

VTRS0.83x

Debt/Equity (TTM)

CORT0.00x

VTRS0.94x

Debt/Assets (TTM)

CORT0.0%

VTRS0.0%

Interest Coverage (TTM)

CORTN/A

VTRSN/A

Net Debt/EBITDA (TTM)

CORT0.00x

VTRS0.00x

Beta

CORT0.52

VTRS0.89

52W Performance

CORT59.3%

VTRS77.1%

YTD Performance

CORT208.4%

VTRS38.4%

% from 52W High

CORT-6.8%

VTRS-6.4%

% from 52W Low

CORT311.0%

VTRS77.3%

Asset Turnover (TTM)

CORT0.99x

VTRS0.40x

FCF Yield (TTM)

CORT0.8%

VTRS9.0%

Earnings Yield (TTM)

CORT0.4%

VTRS-2.0%

Dividend Yield (TTM)

CORTN/A

VTRS2.7%

Rule of 40

CORT28.9

VTRS16.7

EV/GP/RG

CORT0.18

VTRS1.97

Ticker research

View CORT research View VTRS research

Metric	CORT Corcept Therapeutics Inc	VTRS Viatris Inc
Market & Valuation
Market Cap	$12.73B	$20.09B
Enterprise Value	$12.62B	$32.55B
Price	$117.80	$17.25
P/E Ratio	252.72x	N/A
P/S Ratio	15.33x	1.36x
EV/Sales	15.19x	2.21x
EV/EBITDA	1,442.80x	8.00x
P/B Ratio	18.56x	1.42x
P/FCF Ratio	119.10x	11.09x
EV/FCF	118.06x	17.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	28.94x	6.60x
Forward P/S (NTM)	8.27x	1.33x
Revenue & Growth
Revenue (TTM)	$831M	$14.74B
Revenue Growth (YoY)	16.0%	4.4%
Forward Rev Growth	48.8%	2.0%
Profitability
Gross Margin (TTM)	98.3%	40.3%
Operating Margin (TTM)	0.8%	0.0%
EBITDA Margin (TTM)	1.0%	27.2%
Net Margin (TTM)	6.6%	-2.8%
FCF Margin (TTM)	12.9%	12.3%
Net Income (TTM)	$55M	$-411M
FCF (TTM)	$107M	$1.81B
EPS (TTM)	$0.47	-$0.35
ROE (TTM)	8.4%	-279.0%
ROA (TTM)	6.6%	-112.0%
ROIC (TTM)	8.4%	-142.0%
Financial Health
Cash	$111M	$887M
Debt	$0	$13.35B
Net Cash/Debt	$111M	$-12.46B
Current Ratio (TTM)	2.86x	1.58x
Quick Ratio (TTM)	2.63x	0.83x
Debt/Equity (TTM)	0.00x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	0.89
52W Performance	59.3%	77.1%
YTD Performance	208.4%	38.4%
% from 52W High	-6.8%	-6.4%
% from 52W Low	311.0%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.40x
FCF Yield (TTM)	0.8%	9.0%
Earnings Yield (TTM)	0.4%	-2.0%
Dividend Yield (TTM)	N/A	2.7%
Other
Rule of 40	28.9	16.7
EV/GP/RG	0.18	1.97
Ticker research	View CORT research	View VTRS research

Valuation

P/E Ratio

CORT

252.72x

P/S Ratio

VTRS

1.36x

CORT

15.33x

EV/FCF

VTRS

17.96x

CORT

118.06x

Growth & revenue

Revenue Growth TTM

CORT

16.0%

VTRS

4.4%

Forward Revenue Growth

CORT

48.8%

VTRS

2.0%

Profitability & performance

Gross Margin

CORT

98.3%

VTRS

40.3%

ROE

CORT

8.4%

VTRS

-279.0%

FCF Yield %

VTRS

9.0%

CORT

0.8%

52-Week Performance

VTRS

77.1%

CORT

59.3%

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

VTRS

Viatris Inc

Market Cap

CORT$12.73B

VTRS$20.09B

Enterprise Value

CORT$12.62B

VTRS$32.55B

Price

CORT$117.80

VTRS$17.25

P/E Ratio

CORT252.72x

VTRSN/A

P/S Ratio

CORT15.33x

VTRS1.36x

EV/Sales

CORT15.19x

VTRS2.21x

EV/EBITDA

CORT1,442.80x

VTRS8.00x

P/B Ratio

CORT18.56x

VTRS1.42x

P/FCF Ratio

CORT119.10x

VTRS11.09x

EV/FCF

CORT118.06x

VTRS17.96x

PEG Ratio

CORTN/A

VTRSN/A

Forward P/E (NTM)

CORT28.94x

VTRS6.60x

Forward P/S (NTM)

CORT8.27x

VTRS1.33x

Revenue (TTM)

CORT$831M

VTRS$14.74B

Revenue Growth (YoY)

CORT16.0%

VTRS4.4%

Forward Rev Growth

CORT48.8%

VTRS2.0%

Gross Margin (TTM)

CORT98.3%

VTRS40.3%

Operating Margin (TTM)

CORT0.8%

VTRS0.0%

EBITDA Margin (TTM)

CORT1.0%

VTRS27.2%

Net Margin (TTM)

CORT6.6%

VTRS-2.8%

FCF Margin (TTM)

CORT12.9%

VTRS12.3%

Net Income (TTM)

CORT$55M

VTRS$-411M

FCF (TTM)

CORT$107M

VTRS$1.81B

EPS (TTM)

CORT$0.47

VTRS-$0.35

ROE (TTM)

CORT8.4%

VTRS-279.0%

ROA (TTM)

CORT6.6%

VTRS-112.0%

ROIC (TTM)

CORT8.4%

VTRS-142.0%

Cash

CORT$111M

VTRS$887M

Debt

CORT$0

VTRS$13.35B

Net Cash/Debt

CORT$111M

VTRS$-12.46B

Current Ratio (TTM)

CORT2.86x

VTRS1.58x

Quick Ratio (TTM)

CORT2.63x

VTRS0.83x

Debt/Equity (TTM)

CORT0.00x

VTRS0.94x

Debt/Assets (TTM)

CORT0.0%

VTRS0.0%

Interest Coverage (TTM)

CORTN/A

VTRSN/A

Net Debt/EBITDA (TTM)

CORT0.00x

VTRS0.00x

Beta

CORT0.52

VTRS0.89

52W Performance

CORT59.3%

VTRS77.1%

YTD Performance

CORT208.4%

VTRS38.4%

% from 52W High

CORT-6.8%

VTRS-6.4%

% from 52W Low

CORT311.0%

VTRS77.3%

Asset Turnover (TTM)

CORT0.99x

VTRS0.40x

FCF Yield (TTM)

CORT0.8%

VTRS9.0%

Earnings Yield (TTM)

CORT0.4%

VTRS-2.0%

Dividend Yield (TTM)

CORTN/A

VTRS2.7%

Rule of 40

CORT28.9

VTRS16.7

EV/GP/RG

CORT0.18

VTRS1.97

Ticker research

View CORT research View VTRS research

Metric	CORT Corcept Therapeutics Inc	VTRS Viatris Inc
Market & Valuation
Market Cap	$12.73B	$20.09B
Enterprise Value	$12.62B	$32.55B
Price	$117.80	$17.25
P/E Ratio	252.72x	N/A
P/S Ratio	15.33x	1.36x
EV/Sales	15.19x	2.21x
EV/EBITDA	1,442.80x	8.00x
P/B Ratio	18.56x	1.42x
P/FCF Ratio	119.10x	11.09x
EV/FCF	118.06x	17.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	28.94x	6.60x
Forward P/S (NTM)	8.27x	1.33x
Revenue & Growth
Revenue (TTM)	$831M	$14.74B
Revenue Growth (YoY)	16.0%	4.4%
Forward Rev Growth	48.8%	2.0%
Profitability
Gross Margin (TTM)	98.3%	40.3%
Operating Margin (TTM)	0.8%	0.0%
EBITDA Margin (TTM)	1.0%	27.2%
Net Margin (TTM)	6.6%	-2.8%
FCF Margin (TTM)	12.9%	12.3%
Net Income (TTM)	$55M	$-411M
FCF (TTM)	$107M	$1.81B
EPS (TTM)	$0.47	-$0.35
ROE (TTM)	8.4%	-279.0%
ROA (TTM)	6.6%	-112.0%
ROIC (TTM)	8.4%	-142.0%
Financial Health
Cash	$111M	$887M
Debt	$0	$13.35B
Net Cash/Debt	$111M	$-12.46B
Current Ratio (TTM)	2.86x	1.58x
Quick Ratio (TTM)	2.63x	0.83x
Debt/Equity (TTM)	0.00x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	0.89
52W Performance	59.3%	77.1%
YTD Performance	208.4%	38.4%
% from 52W High	-6.8%	-6.4%
% from 52W Low	311.0%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.40x
FCF Yield (TTM)	0.8%	9.0%
Earnings Yield (TTM)	0.4%	-2.0%
Dividend Yield (TTM)	N/A	2.7%
Other
Rule of 40	28.9	16.7
EV/GP/RG	0.18	1.97
Ticker research	View CORT research	View VTRS research